Ipragliflozin, a SGLT2 Inhibitor, Reduced Body Weight and Fat Mass but Not Muscle Mass in Japanese Type 2 Diabetic Patients Treated with Insulin—A Randomized Clinical Trial

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1199-P
Author(s):  
KATSUTARO MORINO ◽  
HIDEKA INOUE ◽  
KEIKO FUSE ◽  
SACHIKO TANAKA ◽  
KEIKO KONDO ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Body Weight ◽  
Randomized Clinical Trial ◽  
Muscle Mass ◽  
Sglt2 Inhibitor ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Reduced Body ◽  
Type 2 Diabetic

scholarly journals Does High-Dose Metformin Cause Lactic Acidosis in Type 2 Diabetic Patients after CABG Surgery? A Double Blind Randomized Clinical Trial

2011 ◽  
Vol 6 (1) ◽  
pp. hi.2011.e8 ◽  
Author(s):  
Afshin Gholipour Baradari ◽  
Mohammad Reza Habibi ◽  
Hadi Darvishi Khezri ◽  
Mohsen Aarabi ◽  
Mohammad Khademloo ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Lactic Acidosis ◽  
Randomized Clinical Trial ◽  
Diabetic Patients ◽  
High Dose ◽  
Type 2 Diabetic Patients ◽  
Double Blind ◽  
Cabg Surgery ◽  
Type 2 Diabetic
Sign in / Sign up

Export Citation Format

Share Document